Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Song Y, Tilly H, Rai S, Zhang H, Jin J, Goto H, Terui Y, Shin HJ, Kim WS, Cao J, Feng J, Eom HS, Kim TM, Tsai XC, Gau JP, Koh H, Zhang L, Song Y, Yang Y, Li W, Huang H, Ando K, Sharman JP, Sehn LH, Bu L, Wang X, Jiang Y, Hirata J, Lee C, Zhu J, Izutsu K.
Song Y, et al. Among authors: gau jp.
Blood. 2023 Apr 20;141(16):1971-1981. doi: 10.1182/blood.2022017734.
Blood. 2023.
PMID: 36626583
Free PMC article.
Clinical Trial.